Immunologic and Infectious Concerns in Uterus Transplantation

Clin Obstet Gynecol. 2022 Mar 1;65(1):37-43. doi: 10.1097/GRF.0000000000000686.

Abstract

Pharmacologic immunosuppression is required for the success of uterus transplantation but can provoke several complications for the transplant recipient. In this review, we discuss the immunologic complications that can occur in the uterus transplant recipient. First, we provide the latest update on immunosuppression regimens used by programs throughout the world. Next, we discuss the prevalence, mechanisms, treatment, and outcome of rejection in uterus transplant recipients. Finally, we discuss infectious complications of varying severity alongside their treatment and impact.

Publication types

  • Review

MeSH terms

  • Female
  • Graft Rejection* / drug therapy
  • Graft Rejection* / prevention & control
  • Humans
  • Immunosuppression Therapy* / adverse effects
  • Uterus / transplantation